[
    [
        {
            "time": "2018-03-15",
            "original_text": "Novo Nordisk launches Rebinyn速, a new, long-acting treatment for patients with hemophilia B in Canada",
            "features": {
                "keywords": [
                    "Rebinyn",
                    "long-acting",
                    "hemophilia B",
                    "Canada"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Novo Nordisk launches Rebinyn速, a new, long-acting treatment for patients with hemophilia B in Canada",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-04-20",
            "original_text": "Novo Nordisk announces the availability of Zonovate速 for the treatment of patients with hemophilia A in Quebec",
            "features": {
                "keywords": [
                    "Zonovate",
                    "hemophilia A",
                    "Quebec"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Novo Nordisk announces the availability of Zonovate速 for the treatment of patients with hemophilia A in Quebec",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]